LifeStance Health (LFST) Change in Accured Expenses (2020 - 2026)

LifeStance Health (LFST) has reported Change in Accured Expenses for 7 consecutive years, with -$26.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 501.05% year-over-year to -$26.4 million; the TTM figure through Mar 2026 stood at -$27.9 million (down 531.84% YoY), while the FY2025 annual figure was -$5.9 million, down 143.49% from the prior year.
• Change in Accured Expenses declined to -$26.4 million in Q1 2026 per LFST's latest filing, from -$2.2 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $60.4 million in Q3 2023 and bottomed at -$55.4 million in Q4 2023.
• Historically, Change in Accured Expenses has averaged -$405705.9 across 5 years, with a median of $2.8 million in 2024.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 1030.22% — and 2026, when it slumped 501.05%.
• LifeStance Health's Change in Accured Expenses stood at -$17.3 million in 2022, then slumped by 220.78% to -$55.4 million in 2023, then jumped by 107.67% to $4.2 million in 2024, then slumped by 152.69% to -$2.2 million in 2025, then sank by 1078.98% to -$26.4 million in 2026.
• Business Quant data shows LFST's Change in Accured Expenses at -$26.4 million in Q1 2026, -$2.2 million in Q4 2025, and -$3.6 million in Q3 2025.